Researchers at Beth Israel Deaconess Medical Center are testing a new approach to fighting COVID-19, using a repurposed antiviral AIDS drug for at-home treatment during the first days of symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death. The nationwide clinical trial is being led by Nathan Shapiro,… Read More »
After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »
Astellas and Seattle Genetics impressed Wall Street last fall when their combination of Padcev and Merck’s Keytruda fought off advanced bladder cancer in previously untreated patients. Friday, the partners presented updated results that look even better. They might even be good enough to snag an expedited regulatory review, analysts say—and at least one market-watcher hiked… Read More »
Last year in Connecticut, a commission was formed to address the state’s specific HIV challenges. This month, the group released its findings in a report that spells out six recommendations for getting to zero new infections, zero HIV-related deaths and zero stigma. (It also released a related video, which you can watch above.) The cover… Read More »
Diabetic, 33, who was left with erectile dysfunction hopes a £1,200 ‘vampire penis injection’ will allow him to start a family with his beloved girlfriend Jimmy Croxton, 33, was diagnosed with type 1 diabetes when he was 18 years old The condition damaged nerves in Mr Croxton’s penis and he couldn’t perform His ’embarrassing’ problems… Read More »